Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
出版年份 2012 全文链接
标题
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 108, Issue 1, Pages 39-48
出版商
Springer Nature
发表日期
2012-11-23
DOI
10.1038/bjc.2012.516
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) K. Fizazi et al. ANNALS OF ONCOLOGY
- Adjuvant therapy in colon cancer
- (2011) Janet S Graham et al. Expert Review of Anticancer Therapy
- Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study
- (2010) Anne Kirstine Hundahl Møller et al. ACTA ONCOLOGICA
- Safety and Efficacy of a Combination of Docetaxel and Cisplatin in Patients With Unknown Primary Cancer
- (2010) Hirofumi Mukai et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site
- (2010) John D. Hainsworth et al. CANCER JOURNAL
- NICE issues guidance on cancer of unknown primary
- (2010) Norra MacReady LANCET ONCOLOGY
- Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis
- (2009) Vassilis Golfinopoulos et al. CANCER TREATMENT REVIEWS
- Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis
- (2009) Antoine Adenis et al. INVESTIGATIONAL NEW DRUGS
- Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site
- (2009) J. D. Hainsworth et al. ONCOLOGIST
- Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors
- (2009) F. Anthony Greco et al. SEMINARS IN ONCOLOGY
- Phase II Trial of Capecitabine and Oxaliplatin in Patients with Adeno- and Undifferentiated Carcinoma of Unknown Primary
- (2009) Katharina Schuette et al. Oncology Research and Treatment
- Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II study
- (2008) George Pentheroudakis et al. ACTA ONCOLOGICA
- Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial
- (2008) G Huebner et al. BRITISH JOURNAL OF CANCER
- Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
- (2008) K Yonemori et al. BRITISH JOURNAL OF CANCER
- Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review
- (2008) George Pentheroudakis et al. CANCER TREATMENT REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now